1. Federal Drug Administration. Guidance for Industry Rheumatoid Arthritis: Developing Drug Products for Treatment. FDA website. May 2013. Available at: www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm354468.pdf. [Last accessed 16 October 2016]
2. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system;M Ostergaard;J Rheumatol,2003
3. Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI;CG Peterfy;Arthritis Res Ther,2012
4. Dynamic magnetic resonance imaging for the evaluation of synovitis in patients with rheumatoid arthritis;K Tamai;Arthritis Rheum,1994
5. Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging;K Gaffney;Ann Rheum Dis,1998